Grover, S A <br/><br/>
How cost-effective is the treatment of dyslipidemia in patients with diabetes but without cardiovascular disease?  [electronic resource] 

 -  Diabetes care  Jan 2001 
 - 45-50 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0149-5992 
<br/><br/><label>Standard No.: </label>10.2337/diacare.24.1.45  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Cardiovascular Diseases--economics<br/>Cost-Benefit Analysis<br/>Diabetes Complications<br/>Drug Costs<br/>Female<br/>Health Care Costs<br/>Humans<br/>Hyperlipidemias--complications<br/>Male<br/>Middle Aged<br/>Primary Prevention<br/>Risk Factors<br/>Simvastatin--economics